Phenylketonuria history and symptoms

Jump to navigation Jump to search

Phenylketonuria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Phenylketonuria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Phenylketonuria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Phenylketonuria

All Images
X-ray X-rays
Ultrasound Echo & Ultrasound
CT CT Images
MRI MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Phenylketonuria

CDC on Phenylketonuria

Phenylketonuria in the news

Blogs on Phenylketonuria

Directions to Hospitals Treating Phenylketonuria

Risk calculators and risk factors for Phenylketonuria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

History and Symptoms

Maternal PKU

Clinical manifestations in the newborn:[1][2]

  • Low weight at birth.
  • Microcephaly.
  • Intellectual disabilities.
  • Congenital heart disease (especially of left heart chambers).
  • Digestive tract deffects.
  • Renal malformations.

Clinical manifestations in the mother:

  • Multiple abortions.

The fetus starts producing PAH hepatic enzyme by the 26thweek of pregnancy, before this, the fetus depends on the mother to metabolize the Phe, and if she has a deficiency of PAH, the fetus will double the Phe blood levels of the mother, which is why women with PKU should follow strict diet and treatment before, and during the pregnancy.

  • Ideal levels of Phe during pregnancy: <180 µmol/L
  • Teratogenic and neurotoxic levels of Phe: 360 µmol/L

References

  1. Waisbren SE, Rohr F, Anastasoaie V, Brown M, Harris D, Ozonoff A; et al. (2015). "Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics". JIMD Rep. doi:10.1007/8904_2014_365. PMID 25712380.
  2. Didycz B, Domagała L, Pietrzyk JJ (2009). "[The maternal phenylketonuria syndrom--still current problem]". Przegl Lek. 66 (1–2): 4–10. PMID 19485248.

Template:WS Template:WH